Phynova Group
Phynova Group is a British life science company, founded in 2002, that develops and commercialises patented natural health ingredients — led by the mulberry-leaf extract Reducose® — and sells them B2B to food, beverage, and supplement brands across global markets via regional distribution partners.
- Company typePrivate
- Founded2002
- HeadquartersHanborough, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Phynova Group does
Phynova Group Ltd is a privately held British life science company, founded in Oxford in 2002, that develops and commercialises natural health ingredients derived from plants with traditional medicine histories. The company operates an R&D platform that converts botanicals — particularly with provenance in traditional Chinese medicine — into novel, science-validated, IP-protected ingredients, supported by a wholly-owned research subsidiary in Beijing, China.
The company's flagship asset is Reducose®, a patented water extract of white mulberry leaves (marketed at 5% concentration) that competitively inhibits alpha-glucosidase enzymes in the small intestine, preventing carbohydrate breakdown for approximately one hour, and is then absorbed and excreted unmetabolized without disrupting the gut microbiome. Reducose® is supported by nine published human clinical trials and is reported to reduce post-meal blood glucose by up to 40%, with additional effects on insulin response, satiety, and second-meal glucose. The company has also developed a microencapsulation technology under Innovate UK grant funding to reduce flavour and texture impact for food and beverage applications.
Phynova monetises Reducose® through a B2B ingredient licensing and sales model, primarily routed via four exclusive regional distribution partners — Bioriginal (North America), Membra (Malaysia), InVita-Trade (Russia/CIS), and Ingredients Plus (Oceania) — and through direct strategic partnerships with consumer brand customers including Nestlé Health Science (Nutren GlucoSmart in South East Asia) and Sugarbreak (Kids' Collection in 1,800 Target stores in the US). Revenue is generated from ingredient sales, turn-key formulation services, and licensing; product pricing is quote-based and not publicly disclosed. The company has 11–50 employees and is registered in England and Wales.
Phynova Group firmographics
Firmographics- Name
- Phynova Group
- Legal name
- Phynova Group Ltd.
- Website
- https://phynova.com
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Phynova Group is a British life science company, founded in 2002, that develops and commercialises patented natural health ingredients — led by the mulberry-leaf extract Reducose® — and sells them B2B to food, beverage, and supplement brands across global markets via regional distribution partners.
- Ownership category
- akta.pro rank
Phynova Group industry classification
Industry- Product category
- Nutraceutical Ingredients
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
- akta.pro primary industry
- Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts) (AFAJAKAD)
- akta.pro secondary industry
- Herbal & Botanical Supplements (CRADAGAD)
Keywords
Where Phynova Group is headquartered
LocationHeadquarters
- HQ city
- Hanborough
- HQ country
- United Kingdom
- HQ region
- Europe
Offices4 records
Markets served
Phynova Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Supply Chain, Marketing or Sales, Personnel
Revenue model
- Ingredient Licensing and Sales: Phynova licenses and sells its Reducose® ingredient to food and beverage manufacturers, supplement brands, and other companies for use in their products. Revenue is generated through ingredient sales and licensing agreements with B2B customers.
- Turn-key Solutions and Formulation Services: Distribution partners like Bioriginal serve customers with Reducose® as a stand-alone ingredient or as a hero-ingredient in turn-key solutions, providing formulation support and ready-to-market concepts.
Go-to-market motion3 records
Distribution channels6 records
Marketing channels6 records
Phynova Group product offering
Product offeringCore offering
Phynova Group develops and commercialises proprietary, science-validated natural health ingredients derived from plants with histories of use in traditional medicine. Its flagship product is Reducose®, a patented water extract of white mulberry leaves that competitively inhibits carbohydrate-digesting enzymes to reduce post-meal blood glucose and insulin response, sold as a B2B ingredient to food, beverage and supplement manufacturers globally.
Product overview
Phynova is a British life science company that develops and commercializes science-proven health ingredients powered by plants. The company's primary product is Reducose®, a patented mulberry leaf extract for blood glucose management. Phynova also maintains a portfolio of functional ingredients, cosmeceuticals, pharmaceuticals, and OTC products based on traditional medicine principles. The company operates an R&D platform that converts plants with traditional use history into novel products validated by contemporary science and protected by intellectual property.
Differentiator
Problem solved
Functional benefit
Brands
- Reducose: Proprietary water extract of mulberry leaf for blood glucose management. Clinically researched ingredient that inhibits carbohydrate-digesting enzymes to reduce post-meal blood sugar and insulin spikes. Available in 5% concentration, vegetarian, plant-based, and allergen-free.
- Chloe LiveLab
Products and services
- Reducose® Reducose® is a proprietary water extract of white mulberry leaves that competitively inhibits alpha-glucosidase enzymes in the small intestine, preventing the breakdown of carbohydrates into glucose for approximately one hour. The ingredient is then absorbed and excreted unmetabolized without affecting the microbiome, reducing postprandial blood glucose and insulin response by up to 40%. Sold B2B to food, beverage and dietary supplement manufacturers for use in blood glucose management products.
- Chloe LiveLab Chloe LiveLab is a collaborative research model co-developed with People Science that enables ingredient suppliers and consumer brands to run real-world evidence studies using continuous glucose monitors and the Chloe app. The first activation showcases Phynova's Reducose® ingredient and is intended to expand to additional functional ingredient categories, inviting other suppliers and brands to participate.
Quantifiable outcome
- 40% reduction in post-meal blood glucose and insulin response
- +5 more outcomes
Companies that use Phynova Group
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Phynova Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Phynova Group partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and flagship.
- People SciencecoreLaunched Chloe LiveLab at SupplySide Global in Las Vegas, a collaborative research model enabling ingredient suppliers and consumer brands to generate real-world evidence through consumer-facing studies. The first activation features Phynova's Reducose® for blood glucose management, with live demonstrations using continuous glucose monitors and the Chloe app.
- Oxford Brookes Centre for Nutrition and HealthcoreCollaborative research partnership for clinical studies on Reducose®. Received Innovate UK grant as part of the 'Better Food for All' programme to investigate long-term benefits of Reducose® and microencapsulation technology. This is the third collaboration between Phynova and OxBCNH.
- Innovate UKcoreInnovate UK, the UK Government Innovation agency, provided grant funding as part of the 'Better Food for All' programme to support research into Reducose® effectiveness in combating excess carbohydrate consumption from modern diets.
- Ingredients PluscoreDistribution partnership for Reducose® for use in Supplement applications to customers in Oceania (Australia and New Zealand). Ingredients Plus is a leading independent distributor in the Asia-Pacific Region.
- INVITA-TradecoreExclusive distribution agreement for Reducose® for use in Food and Supplement applications to customers in Russia, Kazakhstan, Belarus, and Armenia. InVita is a health ingredients specialist distributor with over 20 years industry experience.
- Nestlé Health ScienceflagshipNestlé Health Science launched Nutren GlucoSmart featuring Reducose® in Asia. The product contains clinically studied mulberry leaf extract for 40% reduction of post-prandial blood glucose response. Available as powdered sprinkle format.
- Membrahealth Marketing (M) Sdn BhdcorePartnership for Malaysian market encompassing both distribution to Malaysian customers as well as joint promotion of Reducose® health benefits. Membra serves customers with Reducose® as stand-alone ingredient or as hero-ingredient in turn-key solutions.
- Bioriginal Food & Science CorpcorePartnership for North American market covering both distribution to customers and joint promotion of Reducose® health benefits. Bioriginal serves customers with Reducose® as standalone ingredient or as hero-ingredient in turn-key solutions.
- SugarbreakcorePhynova is a scientific and business partner to Sugarbreak. Their product lines for both adults and children are powered by Phynova's Reducose®, with Kids' Collection available at 1,800 Target stores nationwide in the US.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Phynova Group competitors and assessment
Company assessmentDirect peers
- Sabinsa Corporation: Sabinsa is one of the largest clinically-studied botanical extract suppliers, marketing branded ingredients (e.g., branded extracts for metabolic and joint health) to nutraceutical and functional food manufacturers globally. Closely comparable to Phynova's branded, IP-protected extract model.
- Gencor Pacific: Gencor Pacific develops and licenses branded, clinically studied botanical and nutraceutical ingredients to global supplement and functional food manufacturers. Similar ingredient licensing/royalty revenue model and clinical-validation-led go-to-market as Phynova.
- OmniActive Health Technologies: OmniActive supplies branded, clinically researched plant-derived ingredients (e.g., for metabolic, eye, and joint health) to supplement and functional food brands. Comparable proprietary-extract, B2B-led business model.
- Euromed S.A. Euromed produces standardized botanical extracts and fruit/vegetable-derived actives for nutraceutical and functional food brands. Closely comparable as a science-led, standardized botanical extract B2B supplier operating in similar end-markets to Phynova.
- Indena S.p.A. Indena is an Italian botanical extract manufacturer supplying standardized, science-backed plant-derived ingredients to the nutraceutical, pharmaceutical, and functional food industries. Highly comparable technology, regulatory, and B2B GTM profile to Phynova.
- NuLiv Science: NuLiv Science supplies branded, clinically researched nutraceutical ingredients including metabolic-health actives to global B2B customers. Direct overlap with Phynova's blood-glucose-management positioning and clinical-evidence-led sales motion.
Broad incumbents
- Naturex (Givaudan): Naturex (now part of Givaudan's Taste & Wellbeing division) is a major global supplier of plant-based extracts and natural ingredients to food, beverage, and nutraceutical customers. Overlapping product categories with Phynova but vastly larger portfolio and geographic reach.
- ADM Nutrition: ADM Nutrition is a global agribusiness and ingredient supplier offering a broad range of plant-based functional ingredients to food, beverage, and supplement manufacturers. Substantial overlap on the B2B ingredient side but operates at dramatically greater scale across many product categories.
- Kemin Industries: Kemin is a global ingredient manufacturer supplying branded plant-derived and specialty ingredients across human nutrition, animal nutrition, and personal care. Comparable ingredient B2B model but operates across multiple categories at much greater scale.
- Martin Bauer Group: Martin Bauer is a large, established botanical extract and functional ingredient supplier serving tea, beverage, food, and supplement industries globally. Comparable upstream technology platform but significantly broader scale and category footprint than Phynova.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Phynova Group social profiles
Digital presencePhynova Group compliance and trust
Trust signalCompliance1 record
Phynova Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Phynova Group leadership team
Management profileNumber of profiles
Profiles2 records
Phynova Group subsidiaries and ownership
Company hierarchySubsidiaries1 record
Phynova Group funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Phynova Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Phynova Group
What does Phynova Group do?
Phynova Group develops and commercialises proprietary, science-validated natural health ingredients derived from plants with histories of use in traditional medicine. Its flagship product is Reducose®, a patented water extract of white mulberry leaves that competitively inhibits carbohydrate-digesting enzymes to reduce post-meal blood glucose and insulin response, sold as a B2B ingredient to food, beverage and supplement manufacturers globally.
Is Phynova Group a public or private company?
Phynova Group is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Phynova Group founded?
Phynova Group was founded in 2002. It employs 11 to 50 people.
Where is Phynova Group based?
Phynova Group is headquartered in Hanborough, United Kingdom, in the Europe region.
How does Phynova Group make money?
Two revenue lines are on record. Ingredient Licensing and Sales are the primary driver. The others are turn-key Solutions and Formulation Services.
Who are Phynova Group's main competitors?
Direct peers on record are Sabinsa Corporation, Gencor Pacific, OmniActive Health Technologies, Euromed S.A., Indena S.p.A. and NuLiv Science. Broad incumbents are Naturex (Givaudan), ADM Nutrition, Kemin Industries and Martin Bauer Group.
Does Phynova Group have an API?
No public API is recorded for Phynova Group.
What industry is Phynova Group in?
Phynova Group's product category is Nutraceutical Ingredients. Its primary akta.pro industry code is AFAJAKAD, Botanical & Herbal Extracts (Adaptogens, Polyphenols, Essential Oils, Standardized Extracts), with a secondary code of CRADAGAD, Herbal & Botanical Supplements. Its NAICS code is 325411 and its SIC code is 2833.